Omecamtiv mecarbil for patients with severe systolic dysfunction and hypotension

dc.contributor.author	Crespo-Leiro, María Generosa
dc.contributor.author	McDonagh, Theresa A.
dc.contributor.author	Barge-Caballero, Eduardo
dc.date.accessioned	2023-02-14T08:11:13Z
dc.date.issued	2022-12-21
dc.identifier.citation	Crespo-Leiro MG, McDonagh TA, Barge-Caballero E. Omecamtiv mecarbil for patients with severe systolic dysfunction and hypotension. Eur Heart J. 2022;43(48):5017-19	es_ES
dc.identifier.issn	0195-668X
dc.identifier.uri	http://hdl.handle.net/2183/32471
dc.description	Editorial	es_ES
dc.language.iso	eng	es_ES
dc.publisher	Oxford Academic	es_ES
dc.relation.uri	https://doi.org/10.1093/eurheartj/ehac552	es_ES
dc.rights	This is a pre-copyedited, author-produced version of an article accepted for publication in European Heart Journal following peer review. The version of record is available online at: Oxford Academic web page.	es_ES
dc.title	Omecamtiv mecarbil for patients with severe systolic dysfunction and hypotension	es_ES
dc.type	info:eu-repo/semantics/article	es_ES
dc.rights.access	info:eu-repo/semantics/embargoedAccess	es_ES
dc.date.embargoEndDate	2023-12-21	es_ES
dc.date.embargoLift	2023-12-21
UDC.journalTitle	Euroepan Heart Journal	es_ES
UDC.volume	43	es_ES
UDC.issue	48	es_ES
UDC.startPage	5017	es_ES
UDC.endPage	5019	es_ES